AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $266,000 | +28.5% | 28,343 | +4.7% | 0.00% | +33.3% |
| Q2 2020 | $207,000 | +16.3% | 27,078 | -6.1% | 0.00% | 0.0% |
| Q1 2020 | $178,000 | -36.9% | 28,829 | +24.3% | 0.00% | -25.0% |
| Q4 2019 | $282,000 | +5.6% | 23,199 | +0.5% | 0.00% | 0.0% |
| Q3 2019 | $267,000 | +16.6% | 23,074 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $229,000 | -24.7% | 22,917 | -2.8% | 0.00% | -20.0% |
| Q1 2019 | $304,000 | -11.4% | 23,570 | +4.3% | 0.01% | -16.7% |
| Q4 2018 | $343,000 | -21.0% | 22,600 | +4.2% | 0.01% | 0.0% |
| Q3 2018 | $434,000 | +0.5% | 21,691 | -2.1% | 0.01% | 0.0% |
| Q2 2018 | $432,000 | -5.1% | 22,155 | -1.8% | 0.01% | 0.0% |
| Q1 2018 | $455,000 | +43.5% | 22,568 | -5.6% | 0.01% | +50.0% |
| Q4 2017 | $317,000 | -33.3% | 23,912 | -7.2% | 0.00% | -33.3% |
| Q3 2017 | $475,000 | +0.8% | 25,762 | +0.7% | 0.01% | 0.0% |
| Q2 2017 | $471,000 | -16.0% | 25,587 | +2.9% | 0.01% | -14.3% |
| Q1 2017 | $561,000 | -35.4% | 24,862 | -0.4% | 0.01% | -41.7% |
| Q4 2016 | $868,000 | +36.1% | 24,951 | -4.1% | 0.01% | +33.3% |
| Q3 2016 | $638,000 | +0.9% | 26,018 | -1.6% | 0.01% | +12.5% |
| Q2 2016 | $632,000 | -2.8% | 26,440 | -4.8% | 0.01% | 0.0% |
| Q1 2016 | $650,000 | – | 27,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |